A new drug application was reportedly submitted in late 2025, putting it closest to potential approval
Some early research suggests that semaglutide may be associated with a lower likelihood of developing cannabis use disorder compared with other medications, though this observational finding does not prove causation, and more clinical studies are needed
Similarly, in females, group differences remained highly significant (left: F = 21.04, p 0.25)
You can remain anonymous if you wish or provide contact details if you are willing to share your story to raise awareness and help us in our mission
Because of all this, many people struggle for years before getting the help they need
In this guide, we break down what BPC-157 is, how it works, and why it is frequently examined in research environments